Alogliptin added to sulfonylurea therapy in patients with type 2 diabetes reduces HbA1c without increasing hypoglycemia

被引：0
|
作者：
Pratley, Richard
Kipnes, Mark
Fleck, Penny
Wilson, Craig
Mekki, Qais
机构：
来源：
DIABETES | 2008年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A133 / A133
页数：1
相关论文
共 50 条
  • [31] Trajectories of HbA1c after initiation of insulin therapy in type 2 diabetes mellitus patients
    Mast, R.
    Walraven, I.
    Hoekstra, T.
    Jansen, D.
    van der Heijden, A. A. W.
    Elders, P. J. M.
    Heine, R. J.
    Dekker, J. M.
    Hugtenburg, J. G.
    Nijpels, G.
    DIABETOLOGIA, 2014, 57 : S385 - S385
  • [32] Efficacy and safety of alogliptin added to pioglitazone therapy in patients with type 2 diabetes
    Pratley, Richard
    Reusch, Jane
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2008, 57 : A143 - A143
  • [33] TYPE II DIABETES PREVALENCE, HYPOGLYCEMIA EPISODES, AND HBA1C CONTROL IN BRAZIL
    Flores, N. M.
    Goren, A.
    Gupta, S.
    Pomerantz, D.
    Julian, G.
    VALUE IN HEALTH, 2015, 18 (07) : A865 - A865
  • [34] Efficacy and safety of alogliptin added to metformin therapy in patients with type 2 diabetes
    Nauck, Michael
    Ellis, Graham
    Fleck, Penny
    Wilson, Craig
    Mekki, Qais
    DIABETES, 2008, 57 : A142 - A143
  • [35] The relationship of HbA1c and weight in the treatment of patients with type 2 diabetes
    Mathisen, AL
    Brockley, MR
    DIABETES, 2000, 49 : A117 - A117
  • [36] Mean HbA1c and HbA1c variability are associated with differing diabetes-related complications in patients with type 2 diabetes mellitus
    Wu, Tzu-En
    Su, Yu-Wen
    Chen, Harn-Shen
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 192
  • [37] Proximal HbA1C Level and First Hypoglycemia Hospitalization in Adults With Incident Type 2 Diabetes
    Zhong, Victor W.
    Juhaeri, Juhaeri
    Cole, Stephen R.
    Shay, Christina M.
    Gordon-Larsen, Penny
    Kontopantelis, Evangelos
    Mayer-Davis, Elizabeth J.
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2019, 104 (06): : 1989 - 1998
  • [38] Liraglutide, a human GLP-1 analogue, substantially reduces HbA1c in subjects with type 2 diabetes, irrespective of HbA1c at baseline
    Vaag, A.
    Nauck, M. A.
    Brandle, M.
    Colagiuri, S.
    Schmitz, O.
    Zdravkovic, M.
    Hermansen, K.
    Garber, A.
    Zinman, B.
    DIABETOLOGIA, 2008, 51 : S68 - S69
  • [39] Interpersonal predictors of HbA1c in patients with type 1 diabetes
    Ciechanowski, PS
    Hirsch, IB
    Katon, WJ
    DIABETES CARE, 2002, 25 (04) : 731 - 736
  • [40] Interpersonal predictors of HbA1c in patients with type 1 diabetes
    Ciechanowski, PS
    Hirsch, IB
    Katon, WJ
    DIABETES, 2001, 50 : A48 - A48
12345